EFESO – EFficacy Enterogermina Small Intestinal Bacterial Overgrowth
Condition(s):Irritable Bowel SyndromeLast Updated:July 20, 2009Completed
Hide Studies Not Open or Pending
Condition(s):Irritable Bowel SyndromeLast Updated:July 20, 2009Completed
Condition(s):Small Intestine ProblemLast Updated:October 29, 2019Unknown status
Condition(s):Chronic Abdominal Pain; Small Intestinal Bacterial OvergrowthLast Updated:February 16, 2017Completed
Condition(s):Abdominal DistentionLast Updated:February 29, 2024Not yet recruiting
Condition(s):Systemic Sclerosis; Small Intestinal Bacterial OvergrowthLast Updated:July 30, 2019Completed
Condition(s):Functional Dyspepsia; Small Intestinal Bacterial Overgrowth; Chronic Abdominal DiscomfortLast Updated:October 24, 2012Completed
Condition(s):Small Intestinal Bacterial Overgrowth; Elderly; Male; 16s rRNALast Updated:September 6, 2018Unknown status
Condition(s):Diarrhea Predominant Irritable Bowel Syndrome; Small Intestinal Bacterial OvergrowthLast Updated:July 29, 2015Completed
Condition(s):Irritable Bowel SyndromeLast Updated:November 13, 2020Completed
Condition(s):Irritable Bowel Syndrome; Small Intestinal Bacterial OvergrowthLast Updated:November 8, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.